Your session is about to expire
← Back to Search
Chelation Therapy for Acute Myeloid Leukemia
Study Summary
This trial is testing a drug to see if it can lower the level of metals in the bone marrow and blood of patients with leukemia or myelodysplastic syndrome, and if it helps control the disease or improves response to chemotherapy.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
What clinical indications is Multivitamin typically employed for?
"Multivitamins are a viable solution for toxic encephalopathy and other ailments caused by exposure to elements such as arsenic, mercury, or lead."
Are there any participation vacancies in this trial?
"Affirmative. Clinicaltrials.gov reveals that this clinical trial, which was introduced on October 11th 2018, is currently enrolling participants. 58 people need to be recruited from 1 site for the study to move forward."
Has the FDA sanctioned Multivitamin for widespread usage?
"Due to the preliminary nature of this trial, with limited data for safety and efficacy evaluation, our Power team assigned Multivitamin a score of 1."
What is the cap for participants in this experiment?
"Affirmative. The information hosted on clinicaltrials.gov demonstrates that this medical research, which was posted for the first time on October 11th 2018, is actively recruiting patients. 58 individuals need to be enrolled from a single centre."
Are there any other investigations into the efficacy of Multivitamin for therapeutic gain?
"Currently, only 1 clinical trial is actively exploring the potential of Multivitamin. This study has not reached Phase 3 yet, with most of its experiments taking place in Houston, Texas and one other location."
Share this study with friends
Copy Link
Messenger